首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   352篇
  免费   7篇
耳鼻咽喉   1篇
儿科学   10篇
妇产科学   1篇
基础医学   48篇
口腔科学   41篇
临床医学   20篇
内科学   33篇
神经病学   11篇
特种医学   18篇
外科学   133篇
综合类   15篇
预防医学   14篇
眼科学   5篇
药学   4篇
肿瘤学   5篇
  2020年   2篇
  2018年   4篇
  2015年   9篇
  2014年   10篇
  2013年   21篇
  2012年   13篇
  2011年   8篇
  2010年   12篇
  2009年   2篇
  2008年   12篇
  2007年   6篇
  2005年   2篇
  2004年   4篇
  2003年   3篇
  2002年   6篇
  2001年   2篇
  1999年   6篇
  1998年   5篇
  1997年   10篇
  1996年   4篇
  1995年   9篇
  1994年   2篇
  1993年   4篇
  1992年   8篇
  1991年   5篇
  1990年   12篇
  1989年   8篇
  1988年   3篇
  1987年   5篇
  1986年   10篇
  1985年   6篇
  1984年   5篇
  1983年   3篇
  1982年   4篇
  1981年   3篇
  1979年   3篇
  1978年   5篇
  1977年   12篇
  1976年   16篇
  1975年   12篇
  1974年   10篇
  1973年   12篇
  1972年   12篇
  1971年   9篇
  1970年   11篇
  1969年   6篇
  1967年   5篇
  1966年   3篇
  1965年   3篇
  1964年   3篇
排序方式: 共有359条查询结果,搜索用时 18 毫秒
101.
102.
Pain due to cancer is frequently visceral, and neurolysis of the sympathetic axis has been shown to be an effective and safe method for treating this visceral pain. Several studies have documented the efficacy of neurolytic blocks both by a reduction in the intensity of pain and by a decrease in opioid consumption. Neurolysis of the sympathetic axis should be incorporated into the pain specialist's arsenal as an adjuvant to oral pharmacologic therapy.  相似文献   
103.
OBJECTIVE: Viscosupplementation with hylan G-F 20 has recently become registered for treatment of patients with osteoarthritis (OA) of the knee in most parts of the world. The cost effectiveness and cost utility of this new therapeutic modality were determined as part of a Canadian prospective, randomized, 1-year, open-label, multicentered trial. DESIGN: A total of 255 patients were randomized to 'Appropriate care with hylan G-F 20' (AC+H) or 'Appropriate care without hylan G-F 20' (AC). Costs (1999 Canadian dollars) were collected from the societal viewpoint and included all costs related to OA of the knee and OA in all joints. Patients completed a number of outcomes questionnaires including the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the Health Utilities Index Mark 3 (HUI3). Data were collected at clinic visits (baseline, 12 months) and by telephone (1, 2, 4, 6, 8, 10, and 12 months). RESULTS: The AC+H group over the year had higher costs ($2125-$1415=$710, P< 0.05), more patients improved (69%-40%=29%,P =0.0001), greater increases in HUI3 (0.13-0.03=0.10, P< 0.0001) and increased quality-adjusted life years (QALYs) (0.071, P< 0.05). The incremental cost-effectiveness ratio was $2505/patient improved. The incremental cost-utility ratio was $10000/QALY gained. Sensitivity analyses and a second cost perspective gave similar results. CONCLUSION: The cost-utility ratio is below the suggested Canadian adoption threshold. The results provide strong evidence for adoption of treatment with hylan G-F 20 in the patients and settings studied in the trial.  相似文献   
104.
105.
Low pH values of the stomach contents and activation of the parietal cells are revealed during the spontaneous awakening-associated normothermia of red-cheek sousliks. These factors help maintain the acid-base balance in the organism. Translated fromByulleten' Eksperimental'noi Biologii i Meditsiny, Vol. 120, N o 7, pp. 103–106, July, 1995 Presented by V. P. Kaznacheev, Member of the Russian Academy of Medical Sciences  相似文献   
106.
107.
Summary A multiplicity of surgical operations have been developed in an attempt to achieve satisfactory function after anterior cruciate ligament (ACL) repair. None of these procedures have been able to reproduce the fiber organization anatomy of attachment site, vascularity, or function of the ACL. Twenty-nine foxhounds received a deep-frozen bone-ACL-bone allograft and a ligament augmentation device (LAD). Biomechanical, microvascular, and histological changes were evaluated 3, 6, and 12 months following implantation. The maximum loads of the allograft/LADs were 34.3% (387.2N) after 3 months, 49.3% (556.6N) after 6 months, and 61.1% (698.8N) after a year. The maximum load was 69.1% (780 N). In general, after 6 months the allografts showed normal collagen orientation. The allografts demonstrated no evidence of infection or immune reaction. No bone ingrowth into the LAD was observed. Polarized light microscopy and periodic acid-schiff staining showed that the new bone-ligament substance interface had intact fiber orientation at the area of the ligament insertion. Microvascular examination using the Spalteholtz technique revealed revascularization and the importance of an infrapatellar fat pad for the nourishment of ACL allografts.  相似文献   
108.
109.
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号